NEWRON PHARMACEUT. EO-20 Free Cash Flow Generation Index

Latest as of December 2025: 1.00x

NEWRON PHARMACEUT. EO-20 free cash flow generation index. NEWRON PHARMACEUT. EO-20 (NP5) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of €32.30 Million represents 1% of operating cash flow (€32.35 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

€32.30 Million
EUR

Operating Cash Flow

€32.35 Million
EUR

Capital Expenditures

€48.00K
EUR

Free Cash Flow Generation Index of NEWRON PHARMACEUT. EO-20 (2025–2025)

Free cash flow generation index of NEWRON PHARMACEUT. EO-20 from 2025 to 2025. Historical FCF Generation Index trend for NEWRON PHARMACEUT. EO-20 across 1 annual periods. See how financially flexible is NEWRON PHARMACEUT. EO-20 to measure the company's free cash flow as a share of total liabilities.

NEWRON PHARMACEUT. EO-20 Free Cash Flow Generation Index by Year (2025–2025)

NEWRON PHARMACEUT. EO-20 free cash flow generation index by year from 2025 to 2025. Year-by-year Free Cash Flow Generation Index for NEWRON PHARMACEUT. EO-20. For the full cash flow conversion analysis, see NEWRON PHARMACEUT. EO-20 operating cash flow efficiency.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2025 1.00x €32.30 Million €32.35 Million €48.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).